Singula Bio is a seed-stage biotechnology company that was spun out of the University of Oxford. The company is focused on developing novel neoantigen-based cell therapies for patients with solid tumours. Singula Bio aims to become a world leader in providing individualised cell therapies for cancer. We have developed immunological, medical, surgical and computational technologies to develop selective therapies for difficult-to-treat solid malignancies such as ovarian cancer.
View Top Employees from Singula Bio Ltd.Website | https://singulabio.com/ |
Employees | 8 (8 on RocketReach) |
Industry | Biotechnology Research |
Looking for a particular Singula Bio Ltd. employee's phone or email?
James Hall is the Board Member of Singula Bio Ltd..
8 people are employed at Singula Bio Ltd..